Concerning Alzheimer's disease, Contini et al. reported higher levels of S100A8, S100A9, α-defensins, and cystatins A and B in patients with Alzheimer's disease compared with healthy volunteers [31]. This evidence concerns the gene CSTA and Alzheimer disease.